Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05FZP
|
||||
| Former ID |
DNC013835
|
||||
| Drug Name |
3-(ethoxycarbonyl)phenylboronic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C9H11BO4
|
||||
| Canonical SMILES |
B(C1=CC(=CC=C1)C(=O)OCC)(O)O
|
||||
| InChI |
1S/C9H11BO4/c1-2-14-9(11)7-4-3-5-8(6-7)10(12)13/h3-6,12-13H,2H2,1H3
|
||||
| InChIKey |
REHVCPNQQBDOJJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [1] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
| REF 1 | J Med Chem. 2008 Nov 27;51(22):7057-60.Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.